Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Brentuximab Vedotin Administered Concurrently with Multi-Agent Chemotherapy As Frontline Treatment of ALCL and Other CD3O-Positive Mature T-Cell and NK-Cell Lymphomas 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Fanale, M. A., Shustov, A. R., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Midge, T., Kennedy, D. A., Horwitz, S. M. AMER SOC HEMATOLOGY. 2012
View details for Web of Science ID 000313838900104